Care Access Research Clifton

Clifton, New Jersey 07013

0 studies enrolling now · 1 studies all time

What they study most

Chronic Myelogenous Leukemia - Chronic Phase

Studies at this site

• Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia — Running, not enrolling